NSC |
Compound |
Enrichment |
Correlation |
NSC 619003 |
MX2 HCl |
0.000284051704014449 |
0.69069638 |
NSC 59996 |
Benzaldehyde, 2-amino-, phenylhydrazone (9CI) |
0.000288319947507353 |
0.22168574 |
NSC 679434 |
Null |
0.000288319947507353 |
0.3347211 |
NSC 618939 |
Camptothecin Derivative |
0.000374267341249421 |
0.51594288 |
NSC 625737 |
Null |
0.000374267341249421 |
0.40897153 |
NSC 659949 |
14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone |
0.000374267341249421 |
0.60718037 |
NSC 725774 |
6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.000374267341249421 |
0.52420317 |
NSC 725775 |
6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride |
0.000374267341249421 |
0.45424906 |
NSC 742629 |
Ethylenediaminetetraacetic acid bis-(5-amino salicylic acid methyl ester) |
0.000374267341249421 |
0.39689246 |
NSC 240529 |
2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- |
0.000374267341249427 |
0.53122945 |